ARTICLE | Distillery Therapeutics
The mitochondrial peptidase NLN identified as AML target
May 29, 2020 9:36 PM UTC
INDICATION: Acute myelogenous leukemia (AML)...
BCIQ Company Profiles
INDICATION: Acute myelogenous leukemia (AML)...
BCIQ Company Profiles